Corporate News 14-Sep-16
Ajanta Pharma receives final approval for Aripiprazole Tablets
From USFDA
Ajanta Pharma has received final approval for Aripiprazole Tablets (2mg, 5 mg, 10mg, 15mg, 20mg, 30mg), the bioequivalent generic of Abilify from USFDA. Ajanta Pharma US Inc, a wholly owned subsidiary, will be launching the product into the US market soon.
Previous News
Ajanta Pharma Q2 PAT jumps 25% YoY to Rs 195 cr
( Hot Pursuit - 31-Oct-23 16:27 )
Ajanta Pharma board OKs Rs 315-cr share buyback
( Hot Pursuit - 10-Mar-23 11:54 )
Ajanta Pharma fixes record date for interim dividend
( Market Beat - Reports 05-Nov-19 18:35 )
Board of Ajanta Pharma recommends Interim Dividend
( Corporate News - 29-Oct-21 19:22 )
Ajanta Pharma to announce Quarterly Result
( Corporate News - 24-Jan-23 11:10 )
Volumes spurt at Galaxy Surfactants Ltd counter
( Hot Pursuit - 21-Mar-24 14:30 )
Ajanta Pharma gains after Dahej facility clears USFDA inspection
( Hot Pursuit - 26-Jun-23 09:30 )
Ajanta Pharma consolidated net profit declines 4.93% in the September 2018 quarter
( Results - Announcements 31-Oct-18 17:07 )
Ajanta Pharma
( Results - Analysis 29-Jul-21 20:36 )
Volumes soar at Trident Ltd counter
( Hot Pursuit - 28-Jul-21 11:00 )
Ajanta Pharma to declare Quarterly Result
( Corporate News - 20-Jul-20 14:20 )
Other Stories
ITD Cementation India wins order of Rs 1,937 cr
03-Oct-24 10:35
NIIT Learning Systems allots 1,666 equity shares under ESOP
03-Oct-24 10:30
Ashoka Metcast to discuss results
03-Oct-24 10:29
Emerald Finance to declare Quarterly Result
03-Oct-24 10:29
Rhetan TMT schedules board meeting
03-Oct-24 10:29
Shrenik to table results
03-Oct-24 10:29
Universal Arts to declare Quarterly Result
03-Oct-24 10:28
Three M Paper Boards to conduct board meeting
03-Oct-24 10:28
Arkade Developers to declare Quarterly Result
03-Oct-24 10:28
Worth Investment & Trading Company announces board meeting date
03-Oct-24 10:28
Back
Top
